End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell acute lymphoblastic leukemia

Chintan Parekh, Paul S. Gaynon, Hisham Abdel-Azim

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2040-2043
Number of pages4
JournalPediatric Blood and Cancer
Volume62
Issue number11
DOIs
StatePublished - Nov 1 2015
Externally publishedYes

ASJC Scopus Subject Areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Keywords

  • Minimal residual disease
  • Pediatric
  • T-ALL

Cite this